Cardiac-Specific Overexpression of Catalase Identifies Hydrogen Peroxide-Dependent and -Independent Phases of Myocardial Remodeling and Prevents the Progression to Overt Heart Failure in G&agr;q-Overexpressing Transgenic Mice

Background—Although it seems that reactive oxygen species contribute to chronic myocardial remodeling, questions remain about (1) the specific types of reactive oxygen species involved, (2) the role of reactive oxygen species in mediating specific cellular events, and (3) the cause-and-effect relationship between myocardial reactive oxygen species and the progression to heart failure. Transgenic mice with myocyte-specific overexpression of G&agr;q develop a dilated cardiomyopathy that progresses to heart failure. We used this model to examine the role of H2O2 in mediating myocardial remodeling and the progression to failure. Methods and Results—In G&agr;q myocardium, markers of oxidative stress were increased at 4 weeks and increased further at 20 weeks. G&agr;q mice were crossbred with transgenic mice having myocyte-specific overexpression of catalase. At 4 weeks of age, left ventricular end-diastolic dimension was increased and left ventricular fractional shortening decreased in G&agr;q mice and deteriorated further through 20 weeks. In G&agr;q mice, myocardial catalase overexpression had no effect on left ventricular end-diastolic dimension or fractional shortening at 4 weeks but prevented the subsequent deterioration in both. In G&agr;q mice, myocyte hypertrophy; myocyte apoptosis; interstitial fibrosis; and the progression to overt heart failure, as reflected by lung congestion and exercise intolerance, were prevented by catalase overexpression. Conclusion—In G&agr;q mice, myocyte-specific overexpression of catalase had no effect on the initial phenotype of left ventricular dilation and contractile dysfunction but prevented the subsequent progressive remodeling phase leading to heart failure. Catalase prevented the cellular hallmarks of adverse remodeling (myocyte hypertrophy, myocyte apoptosis, and interstitial fibrosis) and the progression to overt heart failure. Thus, H2O2, associated oxidant pathways, or both play a critical role in adverse myocardial remodeling and the progression to failure.

[1]  J. Lehn,et al.  Enhanced exercise capacity in mice with severe heart failure treated with an allosteric effector of hemoglobin, myo-inositol trispyrophosphate , 2009, Proceedings of the National Academy of Sciences.

[2]  G. Novo,et al.  Biomarkers in heart failure. , 2009, Frontiers in bioscience.

[3]  T. Simić,et al.  Markers of oxidative damage in chronic heart failure: role in disease progression , 2008, Redox report : communications in free radical research.

[4]  Ajay M Shah,et al.  Oxidative stress and redox signalling in cardiac hypertrophy and heart failure , 2006, Heart.

[5]  G. Dorn,et al.  Inhibition of Apoptosis-Regulated Signaling Kinase-1 and Prevention of Congestive Heart Failure by Estrogen , 2007, Circulation.

[6]  J. Sadoshima,et al.  Thioredoxin and ventricular remodeling. , 2006, Journal of molecular and cellular cardiology.

[7]  P. Doevendans,et al.  EUK-8, a superoxide dismutase and catalase mimetic, reduces cardiac oxidative stress and ameliorates pressure overload-induced heart failure in the harlequin mouse mutant. , 2006, Journal of the American College of Cardiology.

[8]  O. Carretero,et al.  Role of inducible nitric oxide synthase in cardiac function and remodeling in mice with heart failure due to myocardial infarction. , 2005, American journal of physiology. Heart and circulatory physiology.

[9]  Douglas L Mann,et al.  Mechanisms and models in heart failure: the biomechanical model and beyond. , 2005, Circulation.

[10]  R. Liao,et al.  Mineralocorticoid Receptor Inhibition Ameliorates the Transition to Myocardial Failure and Decreases Oxidative Stress and Inflammation in Mice With Chronic Pressure Overload , 2005, Circulation.

[11]  D. Sawyer,et al.  Biphasic temporal pattern in exercise capacity after myocardial infarction in the rat: relationship to left ventricular remodeling. , 2005, American journal of physiology. Heart and circulatory physiology.

[12]  Masahiro Ito,et al.  Pressure Overload–Induced Myocardial Hypertrophy in Mice Does Not Require gp91phox , 2004, Circulation.

[13]  A. Takeshita,et al.  Overexpression of Glutathione Peroxidase Prevents Left Ventricular Remodeling and Failure After Myocardial Infarction in Mice , 2004, Circulation.

[14]  G. Dorn,et al.  Inhibition of Cardiac Myocyte Apoptosis Improves Cardiac Function and Abolishes Mortality in the Peripartum Cardiomyopathy of G&agr;q Transgenic Mice , 2003, Circulation.

[15]  A. Sabri,et al.  Regulation of hypertrophic and apoptotic signaling pathways by reactive oxygen species in cardiac myocytes. , 2003, Antioxidants & redox signaling.

[16]  D. Sawyer,et al.  H(2)O(2) regulates cardiac myocyte phenotype via concentration-dependent activation of distinct kinase pathways. , 2003, Journal of molecular and cellular cardiology.

[17]  D. Sawyer,et al.  &bgr;-Adrenergic Receptor–Stimulated Apoptosis in Cardiac Myocytes Is Mediated by Reactive Oxygen Species/c-Jun NH2-Terminal Kinase–Dependent Activation of the Mitochondrial Pathway , 2003, Circulation research.

[18]  A. Takeshita,et al.  Probucol Attenuates Left Ventricular Dysfunction and Remodeling in Tachycardia-Induced Heart Failure: Roles of Oxidative Stress and Inflammation , 2002, Circulation.

[19]  D. Sawyer,et al.  Role of oxidative stress in myocardial hypertrophy and failure. , 2002, Journal of molecular and cellular cardiology.

[20]  D. Sawyer,et al.  Role of reactive oxygen species and NAD(P)H oxidase in alpha(1)-adrenoceptor signaling in adult rat cardiac myocytes. , 2002, American journal of physiology. Cell physiology.

[21]  H. Morita,et al.  Carvedilol Decreases Elevated Oxidative Stress in Human Failing Myocardium , 2002, Circulation.

[22]  D. Sawyer,et al.  Role of reactive oxygen species and NAD(P)H oxidase in alpha(1)-adrenoceptor signaling in adult rat cardiac myocytes. , 2002, American journal of physiology. Cell physiology.

[23]  A. Samarel Gq-coupled receptor signaling in pathological ventricular remodeling. , 2001, Journal of molecular and cellular cardiology.

[24]  W. Colucci,et al.  Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. , 2001, American journal of physiology. Cell physiology.

[25]  Hiroyuki Tsutsui,et al.  Treatment With Dimethylthiourea Prevents Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction in Mice: Role of Oxidative Stress , 2000, Circulation research.

[26]  W. Colucci,et al.  Interleukin-1β and Tumor Necrosis Factor-α Decrease Collagen Synthesis and Increase Matrix Metalloproteinase Activity in Cardiac Fibroblasts In Vitro , 2000 .

[27]  A. Takeshita,et al.  Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium. , 2000, Circulation research.

[28]  W. Colucci,et al.  Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. , 2000, Circulation research.

[29]  A. Takeshita,et al.  Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. , 1999, Circulation research.

[30]  G. Dorn,et al.  Gq signaling in cardiac adaptation and maladaptation. , 1999, Trends in cardiovascular medicine.

[31]  John W. Adams,et al.  Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[32]  A. Omran,et al.  Increased oxidative stress in patients with congestive heart failure. , 1998, Journal of the American College of Cardiology.

[33]  G. Dorn,et al.  Decompensation of Pressure-Overload Hypertrophy in Gαq-Overexpressing Mice , 1998 .

[34]  G. Dorn,et al.  Decompensation of pressure-overload hypertrophy in G alpha q-overexpressing mice. , 1998, Circulation.

[35]  J. T. Saari,et al.  Catalase-overexpressing transgenic mouse heart is resistant to ischemia-reperfusion injury. , 1997, The American journal of physiology.

[36]  G. Dorn,et al.  Transgenic Gαq overexpression induces cardiac contractile failure in mice , 1997 .

[37]  G. Dorn,et al.  Transgenic Galphaq overexpression induces cardiac contractile failure in mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[38]  P. Singal,et al.  Role of oxidative stress in transition of hypertrophy to heart failure. , 1996, Journal of the American College of Cardiology.

[39]  Y. J. Kang,et al.  Suppression of Doxorubicin Cardiotoxicity by Overexpression of Catalase in the Heart of Transgenic Mice (*) , 1996, The Journal of Biological Chemistry.

[40]  J. Robbins,et al.  Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice. , 1991, The Journal of biological chemistry.